de Vries EGE - Search Results

1

The gut wall's potential as a partner for precision oncology in immune checkpoint treatment.

Hone Lopez S, Jalving M, Fehrmann RSN, Nagengast WB, de Vries EGE, de Haan JJ. Hone Lopez S, et al. Among authors: de vries ege, de haan jj. Cancer Treat Rev. 2022 Jun;107:102406. doi: 10.1016/j.ctrv.2022.102406. Epub 2022 May 9. Cancer Treat Rev. 2022. PMID: 35569388 Free article. Review.

2

Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction.

Koornstra JJ, Jalving M, Rijcken FE, Westra J, Zwart N, Hollema H, de Vries EG, Hofstra RW, Plukker JT, de Jong S, Kleibeuker JH. Koornstra JJ, et al. Eur J Cancer. 2005 May;41(8):1195-202. doi: 10.1016/j.ejca.2005.02.018. Eur J Cancer. 2005. PMID: 15911244

3

TRAIL induces apoptosis in human colorectal adenoma cell lines and human colorectal adenomas.

Jalving M, de Jong S, Koornstra JJ, Boersma-van Ek W, Zwart N, Wesseling J, de Vries EG, Kleibeuker JH. Jalving M, et al. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4350-6. doi: 10.1158/1078-0432.CCR-05-2487. Clin Cancer Res. 2006. PMID: 16857810

4

In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.

Nagengast WB, de Vries EG, Hospers GA, Mulder NH, de Jong JR, Hollema H, Brouwers AH, van Dongen GA, Perk LR, Lub-de Hooge MN. Nagengast WB, et al. J Nucl Med. 2007 Aug;48(8):1313-9. doi: 10.2967/jnumed.107.041301. Epub 2007 Jul 13. J Nucl Med. 2007. PMID: 17631557 Free article.

5

Profiling studies in ovarian cancer: a review.

Fehrmann RS, Li XY, van der Zee AG, de Jong S, Te Meerman GJ, de Vries EG, Crijns AP. Fehrmann RS, et al. Oncologist. 2007 Aug;12(8):960-6. doi: 10.1634/theoncologist.12-8-960. Oncologist. 2007. PMID: 17766655 Free article. Review.

6

Evidence based selection of housekeeping genes.

de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, Kamps WA, de Vries EG, van der Zee AG, te Meerman GJ, ter Elst A. de Jonge HJ, et al. PLoS One. 2007 Sep 19;2(9):e898. doi: 10.1371/journal.pone.0000898. PLoS One. 2007. PMID: 17878933 Free PMC article.

7

A new perspective on transcriptional system regulation (TSR): towards TSR profiling.

Fehrmann RS, de Jonge HJ, Ter Elst A, de Vries A, Crijns AG, Weidenaar AC, Gerbens F, de Jong S, van der Zee AG, de Vries EG, Kamps WA, Hofstra RM, Te Meerman GJ, de Bont ES. Fehrmann RS, et al. PLoS One. 2008 Feb 20;3(2):e1656. doi: 10.1371/journal.pone.0001656. PLoS One. 2008. PMID: 18297136 Free PMC article.

8

Survival-related profile, pathways, and transcription factors in ovarian cancer.

Crijns AP, Fehrmann RS, de Jong S, Gerbens F, Meersma GJ, Klip HG, Hollema H, Hofstra RM, te Meerman GJ, de Vries EG, van der Zee AG. Crijns AP, et al. PLoS Med. 2009 Feb 3;6(2):e24. doi: 10.1371/journal.pmed.1000024. PLoS Med. 2009. PMID: 19192944 Free PMC article.

9

Multidrug resistance in oncology and beyond: from imaging of drug efflux pumps to cellular drug targets.

Nagengast WB, Oude Munnink TH, Dijkers EC, Hospers GA, Brouwers AH, Schröder CP, Lub-de Hooge M, de Vries EG. Nagengast WB, et al. Methods Mol Biol. 2010;596:15-31. doi: 10.1007/978-1-60761-416-6_2. Methods Mol Biol. 2010. PMID: 19949918

10

89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922.

Nagengast WB, de Korte MA, Oude Munnink TH, Timmer-Bosscha H, den Dunnen WF, Hollema H, de Jong JR, Jensen MR, Quadt C, Garcia-Echeverria C, van Dongen GA, Lub-de Hooge MN, Schröder CP, de Vries EG. Nagengast WB, et al. J Nucl Med. 2010 May;51(5):761-7. doi: 10.2967/jnumed.109.071043. Epub 2010 Apr 15. J Nucl Med. 2010. PMID: 20395337 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

552 results

Search Page